Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15Stomach Neoplasms 8Carcinoma, Hepatocellular 8Rectal Neoplasms 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Brain Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Recurrence 4Urinary Bladder Neoplasms 3Pilonidal Sinus 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Melanoma 3Lung Neoplasms 3Kidney Neoplasms 3Glioblastoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Pain, Postoperative 2Pain 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Liver Neoplasms 2Gastrointestinal Stromal Tumors 2

Interventions

Cabergoline 2Surgical Procedures, Operative 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prolactinoma × Surgical Procedures, Operative × Clear all
NCT03717454 2018-11-20

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Ruijin Hospital

Phase NA Unknown
50 enrolled

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡